Quote | Arcus Biosciences Inc. (NYSE:RCUS)
|Last Trade Date Time:||06/09/2023 03:00:00 am|
News | Arcus Biosciences Inc. (NYSE:RCUS)
– Clinically Meaningful Reduction in Risk of Progression or Death Was Observed in the Domvanalimab-Containing Study Arms Compared to Zimberelimab Monotherapy in First-Line, PD-L1-High NSCLC – – Objective Response Rate (ORR) Improved in Both Domvanalimab-Containing...
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in a fireside chat at the upcoming Goldman Sachs 44 th Annual ...
Message Board Posts | Arcus Biosciences Inc. (NYSE:RCUS)
|Biotechs are starting to react to news...finally.||conix||investorshub||04/05/2022 3:26:51 PM|
|The stock didn't react as well as expected||dinogreeves||investorshub||05/27/2020 12:46:59 PM|
|Also in the DEF 14.....didnt see any information||lovetc||investorshub||04/22/2020 2:48:12 AM|
|shorted some and bought some put at $31||lovetc||investorshub||04/22/2020 2:46:30 AM|
|RCUS will likely hit 40 this week and||dinogreeves||investorshub||04/21/2020 1:25:35 AM|
Arcus Biosciences Inc. Company Name:
RCUS Stock Symbol:
Arcus Biosciences Inc. Website:
News, Short Squeeze, Breakout and More Instantly...